Published in Gene Therapy Weekly, January 18th, 2001
A report on the findings was published in the January 2001 issue of the Journal of Clinical Oncology.
The vaccine, tested on 14 patients, uses lab-grown pancreatic cancer cells genetically-modified with the immune-boosting gene GM-CSF.
After surgery to remove the pancreatic cancers, patients received varying doses of the vaccine. Twelve of the 14 then underwent radiation and chemotherapy following the initial vaccination. Six patients received up to three additional monthly...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2001-01-18)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.